Markets Open
Global Markets
S&P 500 7,375.43 ▲ +0.8% DOW 51,723.15 ▲ +0.3% NASDAQ 24,933.96 ▲ +2.0% RUSSELL 2K 2,914.86 ▲ +0.3% VIX 18.92 ▼ -8.4% GOLD 4,153.1 ▲ +2.9% CRUDE OIL 84.54 ▲ +0.1% EUR/USD 1.15 ▲ +1.2% BTC 64,678 ▲ +1.1% ETH 1,916.84 ▲ +1.3%
Markets

Procter & Gamble earnings prompt Cramer trust to exit stake

Procter & Gamble shares fell after flat organic sales and soft fiscal 2027 guidance, as Jim Cramer’s Charitable Trust sold its remaining stake.

Sarah Jenkins

By Sarah Jenkins · Chief Macro Economics Correspondent

· 3 min read

Procter & Gamble earnings prompt Cramer trust to exit stake
Photo: CNBC

Procter Gamble earnings disappointed on revenue momentum, with organic sales flat against analyst expectations for about 2% growth, according to CNBC and LSEG data cited by the network. Shares of Procter & Gamble were down about 3%, or roughly $4.50, in premarket trading after the household products company reported mixed quarterly results and issued a restrained fiscal 2027 outlook.

CNBC’s Investing Club said Jim Cramer’s Charitable Trust would sell its remaining 200 shares of Procter & Gamble at about $144 shortly after the opening bell. After that transaction, the trust would no longer hold a position in the company’s stock, CNBC said.

The planned exit followed a prior reduction on Tuesday, when the trust sold 100 shares at around $151, according to CNBC. The Investing Club said the position had been built between November 2025 and March 2026 and that the final sale would lock in a small loss of less than 1%. CNBC said the stake had originally been established as a defensive hedge.

Why did Procter & Gamble stock fall after earnings?

Investors reacted to weak underlying sales growth and guidance that left little room above Wall Street’s existing expectations. Organic sales, a measure that strips out effects such as currency moves, acquisitions and divestitures, are closely watched because they show whether demand and pricing are improving in the company’s core business.

Procter & Gamble’s organic sales were unchanged in the quarter, CNBC reported, below analysts’ forecast for roughly 2% growth. The Beauty division was the only business segment to produce positive organic sales growth, CNBC said. That unit includes brands such as Head & Shoulders, Pantene and Old Spice.

Profit was stronger than expected, though still lower than a year earlier. Earnings per share fell 3% year over year to $1.43, compared with the $1.41 expected by analysts, according to LSEG data cited by CNBC.

What Procter & Gamble said about fiscal 2027

For fiscal 2027, Procter & Gamble projected organic sales growth of 1% to 3%, CNBC reported. That range brackets analysts’ expectation for about 2% growth.

The company also forecast earnings per share of $6.89 to $7.11. The midpoint, $7.00, was below the $7.02 analyst consensus cited by CNBC.

Procter & Gamble estimated a roughly $1 billion after-tax hit in fiscal 2027 from higher raw material, energy and transportation costs, according to CNBC. Those input costs reduce earnings because they raise the expense of making and distributing consumer products unless offset by pricing, productivity gains or lower costs elsewhere.

CNBC’s Investing Club said Procter & Gamble has historically issued conservative forecasts and said the outlook could improve if the Iran war reaches a durable conclusion and energy and input costs decline for a sustained period. That was presented as the club’s assessment, rather than company guidance.

The club also said it wanted to see stronger growth under Chief Executive Shailesh Jejurikar, who took over in January. CNBC reported that the trust was not dismissing the possibility that Jejurikar’s plan could lift growth, but preferred to track that progress without holding the shares.

This story draws on original reporting from CNBC.

More from Markets

All Markets →